Studies performed in mice bearing brain metastases of breast cancer have shown that systemic administration of relatively high doses of TNF can induce BBTB permeabilization [23] and enhance tumor penetration of therapeutic compounds [60], but, as discussed above, this approach cannot be used in patients because of its inherent systemic toxicity [12]. The gene discussed is TNF; the disease is neoplasm.